Jonathan E. Lim, President, CEO at HALOZYME THERAPEUTICS INC (HALO), sold 25,000 shares at $9.04 ($226K) on 2007-10-31, disclosed to the SEC on 2007-11-02.
Scheduled sale ($226k) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.01 | 400 | $4K | 1.6% |
| 2 | $9.02 | 4,700 | $42K | 18.8% |
| 3 | $9.03 | 12,700 | $115K | 50.8% |
| 4 | $9.04 | 4,700 | $42K | 18.8% |
| 5 | $9.05 | 710 | $6K | 2.8% |
| 6 | $9.06 | 1,090 |
| $10K |
| 4.4% |
| 7 | $9.07 | 300 | $3K | 1.2% |
| 8 | $9.15 | 300 | $3K | 1.2% |
| 9 | $9.16 | 100 | $916 | 0.4% |
| Total | $9.03 avg | 25,000 | $226K | 100% |
| Filing → |
| ERAS | BUY | 2023-06-08 | $275K | — | Filing → |
| ERAS | BUY | 2023-03-28 | $284K | — | Filing → |
| ERAS | BUY | 2023-01-10 | $232K | — | Filing → |